Anti-angiogenesis strategies in cancer therapies
| Other Authors: | , |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Amsterdam :
Elsevier/AP, Academic Press is an imprint of Elsevier
c2017
|
| Subjects: |
Table of Contents:
- 1. Angiogenesis and anti-angiogenesis strategies in cancer
- 2. Models for assessing anti-angiogenesis agents: appraisal of current techniques
- 3. Anti-angiogenesis in multiple myeloma
- 4. Interface between Thrombosis-Inflammation and Angiogenesis in cancer progression
- 5. MicroRNAs and Angiogenesis
- 6. Naturally occurring angiogenesis inhibitors
- 7. Integrin antagonists and angiogenesis
- 8. Tyrosine kinase inhibitors and angiogenesis
- 9. Tetraiodothyroacetic acid at integrin avB3: a model of pharmaceutical anti-angiogenesis
- 10. Anti-angiogenesis therapy and its combinations with chemotherapy: impact on primary tumor and its metastasis
- 11. Application of nanotechnology to target tumor angiogenesis in cancer therapeutics
- 12. New directions in anti-angiogenesis research